Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;109:e316
doi: 10.1161/01.CIR.0000129326.31606.B1
This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsuda, K.
Right arrow Articles by Karpe, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsuda, K.
Right arrow Articles by Karpe, F.
Related Collections
Right arrow Obesity
Right arrow Lipid and lipoprotein metabolism
Right arrow Endothelium/vascular type/nitric oxide

(Circulation. 2004;109:e316.)
© 2004 American Heart Association, Inc.


Correspondence

Role of Leptin in Regulating Nitric Oxide Production and Membrane Microviscosity

Kazushi Tsuda, MD; Ichiro Nishio, MD

Division of Cardiology, Department of Medicine, Wakayama Medical University, Wakayama, Japan, tsudak{at}mail.wakayama-med.ac.jp

To the Editor:

We read with interest the article by Ardilouze et al1 dealing with the possible roles of nitric oxide (NO) and adrenergic stimulation in the regulation of subcutaneous adipose tissue blood flow in humans. The results of their study demonstrated that NO seems to determine the absolute level of adipose tissue blood flow, whereas the postprandial enhancement of adipose tissue blood flow is highly dependent on ß-adrenergic stimulation. The authors proposed that NO and ß-adrenergic receptors may be major regulators of subcutaneous adipose tissue blood flow in humans.

There is evidence that leptin, which is secreted from adipose tissue, might actively participate in the regulation of NO production. Nickola et al2 showed that leptin attenuated cardiac contraction in rat ventricular myocytes, possibly through an increased NO production. In a study we presented previously, a relationship between membrane fluidity (a reciprocal value of membrane microviscosity) of erythrocytes and leptin was investigated by means of an electron paramagnetic resonance method.3 The decreased membrane fluidity of erythrocytes might cause a disturbance in the blood rheologic behavior and the microcirculation, which could contribute, at least in part, to the pathophysiology of circulatory disorders.4 We demonstrated that leptin increased the membrane fluidity of erythrocytes and improved the rigidity of cell membranes in humans via the NO- and cGMP-dependent mechanism.3 One hypothesis is that leptin may actively participate in the improvement of the rheologic behavior of erythrocytes and the microcirculation in humans by increasing NO production. In a separate series of the experiment, we showed that the relaxing effect of leptin on blood vessels was partially mediated by the NO-dependent pathway.5 In this context, we speculate that leptin-induced NO production with a concomitant improvement of erythrocyte membrane microviscosity could partially modulate the adipose tissue blood flow in humans. Therefore, we would like to know whether the adipose tissue blood flow might be correlated with the plasma leptin level in the current study of Dr Ardilouze and colleagues.1 It would be necessary to assess more precisely the functional interactions between leptin and NO in the regulation of membrane microviscosity and their contribution to the mechanism underlying increased adipose tissue blood flow in humans.

References

1. Ardilouze JL, Fielding BA, Currie JM, et al. Nitric oxide and ß-adrenergic stimulation are major regulators of preprandial and postprandial subcutaneous adipose tissue blood flow in humans. Circulation. 2004; 109: 47–45.[Abstract/Free Full Text]

2. Nickola M, Wold LE, Colligan PB, et al. Leptin attenuates cardiac contraction in rat ventricular myocytes: role of NO. Hypertension. 2000; 36: 501–505.[Abstract/Free Full Text]

3. Tsuda K, Kimura K, Nishio I. Leptin improves membrane fluidity of erythrocytes in humans via a nitric oxide-dependent mechanism: an electron paramagnetic resonance investigation. Biochem Biophys Res Commun. 2002; 297: 672–681.[CrossRef][Medline] [Order article via Infotrieve]

4. Tsuda K, Nishio I. Membrane fluidity and hypertension. Am J Hypertens. 2003; 16: 244–248.[Medline] [Order article via Infotrieve]

5. Kimura K, Tsuda K, Baba A, et al. Involvement of nitric oxide in endothelium-dependent arterial relaxation by leptin. Biochem Biophys Res Commun. 2002; 273: 745–749.[CrossRef]


 

Response

Jean-Luc Ardilouze, MD; Barbara A. Fielding, PhD; Jenny M. Curry, BSc; Keith N. Frayn, PhD, ScD; Fredrik Karpe, MD, PhD

Oxford Centre for Diabetes, Endocrinology, and Metabolism, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK

We thank Drs Tsuda and Nishio for indicating a potential link between leptin produced in adipocytes and the role of NO for adipose tissue vascular function. In 2 separate in vitro studies, they have found that phenylephrine-contracted arterial rings were relaxed by leptin (an effect mediated through endothelial NO production1) and that leptin appears to have a direct effect on red blood cell membrane fluidity.2 Theoretically, both mechanisms could work in concert to increase blood flow. In tissues with a high local concentration of leptin, such as adipose tissue, this mechanism could be of particular importance. Unfortunately, we have not determined tissue concentrations of leptin in our experiments. Therefore, we cannot test this hypothesis. However, the factors determining tissue blood flow arise from an integrated physiological response.3 This is well demonstrated in our study of adipose tissue.4 On the one hand, we found that local production of NO is a major regulator of blood flow; on the other hand, we showed that blockade of ß-adrenoreceptor function abolishes the augmented blood flow seen after a meal. The latter is likely to depend on sympathetic activation originating from the central nervous system. We are only aware of one study in which adipose tissue generation of leptin, observed within a wide range of obesity, has been quantified along with tissue blood flow.5 It clearly shows that obese women produce more leptin per unit of adipose tissue, yet their blood flow is substantially lower than in lean women. In order to reconcile this observation with the apparent contradictory in vitro effects suggested by Tsuda et al, we can think of 3 different explanations. First, the observation may reflect leptin resistance, which has been demonstrated in other systems involving this hormone. Second, there might be an as-yet-unidentified counterbalancing effect in adipose tissue. Third, the in vitro effects have limited relevance in vivo.

References

1. Kimura K, Tsuda K, Baba A, et al. Involvement of nitric oxide in endothelium-dependent arterial relaxation by leptin. Biochem Biophys Res Commun. 2000; 273: 745–749.[CrossRef][Medline] [Order article via Infotrieve]

2. Tsuda K, Kimura K, Nishio I. Leptin improves membrane fluidity of erythrocytes in humans via a nitric oxide-dependent mechanism: an electron paramagnetic resonance investigation. Biochem Biophys Res Commun. 2002; 297: 672–681.[CrossRef][Medline] [Order article via Infotrieve]

3. Frayn KN, Karpe F, Fielding BA, et al. Integrative physiology of human adipose tissue. Int J Obes Relat Metab Disord. 2003; 27: 875–888.[CrossRef][Medline] [Order article via Infotrieve]

4. Ardilouze JL, Fielding BA, Currie JM, et al. Nitric oxide and ß-adrenergic stimulation are major regulators of preprandial and postprandial adipose tissue blood flow in humans. Circulation. 2004; 109: 47–52.[Abstract/Free Full Text]

5. Klein S, Horowitz JF, Landt M, et al. Leptin production during early starvation in lean and obese women. Am J Physiol Endocrinol Metab. 2000; 278: E280–E284.[Abstract/Free Full Text]





This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsuda, K.
Right arrow Articles by Karpe, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsuda, K.
Right arrow Articles by Karpe, F.
Related Collections
Right arrow Obesity
Right arrow Lipid and lipoprotein metabolism
Right arrow Endothelium/vascular type/nitric oxide